malignant mesothelioma pathology

malignant mesothelioma pathology

The Food and Drug Administration (FDA) has approved a combination of pemetrexed and cisplatin for treatment of mesothelioma and other asbestos diseases partners. The becomes the first and the only drug that has been shown to help treat patients with mesothelioma asbestos having any disease associated with FDA-approved. ALIMTA was approved for use with cisplatin, a good agent chemotherapy approved for the treatment of malignant mesothelioma, a lethal tumor of the lung lining in patients with mesothelioma who do not want surgery. One of the most deadly, painful and devastating cancers that a person can have malignant mesothelioma. There are about 10,000 and 15,000 annual mesothelioma patients diagnosed with malignant mesothelioma in the world, and greatly increases each year. Some people do not even know they have mesothelioma malignant until it has reached a stage of severe and advanced, so mesothelioma treatment options of surgery or radiotherapy is not necessary. ALIMTA / cisplatin has shown be quite different. A comparison of this combination with cisplatin alone with about 448 patients with mesothelioma in 19 countries – the largest test to date among patients with malignant mesothelioma mesothelioma. The results show is that the overall survival rate was 30% higher (about ALIMTA / cisplatin was used 12.1 months compared to 9.3 months for cisplatin alone), and about 50.3% of mesothelioma patients undergoing ALIMTA / cisplatin lived one year after treatment, compared with 38.0% who had cisplatin alone. It has been demonstrated for the first time that chemotherapy helps patients with malignant mesothelioma mesothelioma prolong his life, that is something that we have. Furthermore, research has also shown that there was an improvement in lung function when using the Alimta / cisplatin, compared with the use of cisplatin alone. However, there is some information vital security. There are no hematolgoic and hematologic side effects associated with the use of pemetrexed and are anemia, neutropenia, nausea, thrombocytopenia, vomiting, diarrhea, fatigue, pain and rash. In order to decrease the severity of side effects, all patients with mesothelioma using pemetrexed should take a dose of folic acid and intramuscular injections of vitamin B12 daily.

About the Author:

My favourite blog – Mesothelioma Portal

Article Source: ArticlesBase.comAlimta and Cisplatin for Mesothelioma Treatments

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Leave a Reply